These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6215075)

  • 1. Heterogeneity of the response of chronic lymphocytic leukemia cells to phorbol ester.
    Okamura J; Gelfand EW; Letarte M
    Blood; 1982 Nov; 60(5):1082-8. PubMed ID: 6215075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens.
    Gordon J; Mellstedt H; Aman P; Biberfeld P; Klein G
    J Immunol; 1984 Jan; 132(1):541-7. PubMed ID: 6606672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of chronic lymphocytic leukemia cells by phorbol ester: increase in Ia expression, IgM secretion and MLR stimulatory capacity.
    Okamura J; Letarte M; Stein LD; Sigal NH; Gelfand EW
    J Immunol; 1982 May; 128(5):2276-80. PubMed ID: 6460820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro maturation of B cells in chronic lymphocytic leukemia. I. Synergistic action of phorbol ester and interleukin 2 in the induction of Tac antigen expression and interleukin 2 responsiveness in leukemic B cells.
    Kabelitz D; Pfeffer K; von Steldern D; Bartmann P; Brudler O; Nerl C; Wagner H
    J Immunol; 1985 Oct; 135(4):2876-81. PubMed ID: 2993419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.
    Danersund A; Tötterman TH; Nilsson K; Egle-Jansson I; Kabelitz D; Sjöberg O
    Clin Exp Immunol; 1985 Mar; 59(3):644-52. PubMed ID: 3872753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells.
    Tötterman TH; Nilsson K; Sundström C
    Nature; 1980 Nov; 288(5787):176-8. PubMed ID: 7432517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response of non-T, non-B acute lymphocytic leukemia cells to phorbol ester.
    Okamura J; Gelfand EW; Letarte M
    Cancer Res; 1984 Mar; 44(3):1246-51. PubMed ID: 6581867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phorbol ester treated chronic B lymphocytic leukaemia cells induce autologous T cell proliferation without generation of cytotoxic T cells.
    Kabelitz D; Tötterman TH; Nilsson K; Gidlund M
    Clin Exp Immunol; 1984 Aug; 57(2):461-6. PubMed ID: 6235991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetate.
    Guy K; Van Heyningen V; Dewar E; Steel CM
    Eur J Immunol; 1983 Feb; 13(2):156-9. PubMed ID: 6403357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of mixed lymphocyte response. Stimulatory activity by phorbol ester.
    Okamura J; Letarte M; Gelfand EW
    J Clin Immunol; 1984 May; 4(3):228-34. PubMed ID: 6330158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phorbol ester-induced differentiation of a non-T, non-B leukemic cell line: model for human lymphoid progenitor cell development.
    LeBien TW; Bollum FJ; Yasmineh WG; Kersey JH
    J Immunol; 1982 Mar; 128(3):1316-20. PubMed ID: 7035564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations in cell surface phenotype of T- and B-cell chronic lymphocytic leukemia cells following in vitro differentiation by phorbol ester.
    Shawler DL; Glassy MC; Wormsley SB; Royston I
    J Natl Cancer Inst; 1984 May; 72(5):1059-63. PubMed ID: 6609264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of chronic lymphocytic leukemia cells after in vitro treatment with Epstein-Barr virus or phorbol ester. I. Immunologic and morphologic studies.
    Deegan MJ; Maeda K
    Am J Hematol; 1984; 17(4):335-47. PubMed ID: 6093504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phorbol ester induction of plasmacytoid and hairy cell leukemia features in B-type lymphocytic leukemias: the relation to B-cell differentiation and maturation.
    Gazitt Y; Polliack A
    Blood Cells; 1987; 12(2):413-39. PubMed ID: 3497682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid morphological and substratum adherence response by hairy cell and other human leukemic cells to phorbol ester tumor promoters.
    Lockney MW; Golomb HM; Dawson G
    Leuk Res; 1985; 9(2):297-304. PubMed ID: 3990337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phorbol ester-induced loss of colchicine ultrasensitivity in chronic lymphocytic leukaemia lymphocytes.
    O'Connor TW
    Leuk Res; 1985; 9(7):885-95. PubMed ID: 2991669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochemical analysis of acid hydrolases expression during phorbol diester (TPA)-driven differentiation of B-chronic lymphocytic leukaemia cells in vitro.
    Dufer J; Bernard J
    Leuk Res; 1984; 8(5):813-20. PubMed ID: 6333564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of normal differentiation in mouse and human myeloid leukemic cells by phorbol esters and the mechanism of tumor promotion.
    Lotem J; Sachs L
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5158-62. PubMed ID: 291929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoid colony growth with phorbol myristate acetate and lymphocyte-conditioned media in chronic lymphocytic leukemia and malignant lymphomas.
    Maksymiuk AW; Skinnider LF
    Cancer Invest; 1985; 3(5):427-33. PubMed ID: 4052832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tpa-induced maturation in secretory human B-leukemic cells in vitro: DNA synthesis, antigenic changes, and immunoglobulin secretion.
    Efremidis AP; Haubenstock H; Holland JF; Bekesi JG
    Blood; 1985 Oct; 66(4):953-60. PubMed ID: 3876126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.